StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) stock

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Vicapsys Life Sciences's enterprise value was $12.86M on Oct 19, 2026, against $48.47M a year earlier. Over the last 5 years it ranged from $12.86M to $226.51M, with a median of $48.47M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$12.86M-73.5%
2025Dec 31, 2025$48.47M-78.6%
2024Dec 31, 2024$226.51M+157.8%
2023Dec 29, 2023$87.86M+181.9%
2022Dec 30, 2022$31.16M-10.6%
2021Dec 31, 2021$34.85M+32.9%
2020Dec 31, 2020$26.22M–

More Vicapsys Life Sciences figures

See a number that looks wrong?